Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 26 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

8%

2 trials in Phase 3/4

Results Transparency

0%

0 of 11 completed trials have results

Key Signals

7 recruiting

Enrollment Performance

Analytics

N/A
15(88.2%)
Phase 3
1(5.9%)
Phase 4
1(5.9%)
17Total
N/A(15)
Phase 3(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (26)

Showing 20 of 26 trials
NCT07496242Recruiting

Immunological Phenotype of Desmoid-fibromatosis-affected Patients.

Role: collaborator

NCT07451639Not ApplicableCompleted

Effect of a Reducose®-Based Supplement on Metabolic Health in Subjects With Metabolic Syndrome

Role: lead

NCT07023211Not ApplicableCompleted

Neofunctional Deep Breathing for Stress Modulation

Role: lead

NCT05883878Not ApplicableRecruiting

Innovative Approaches for Personalised Cardiovascular Prevention

Role: collaborator

NCT06086132Recruiting

Detection and Prevention of Cancer-Related Cardiovascular Toxicity Registry

Role: collaborator

NCT06595212Recruiting

Genetics and Environment iNtersection In the ALS-FTD Spectrum: an Italian Twins Cohort studY With a Multi-Omics Approach

Role: collaborator

NCT06785597Recruiting

EpigenOMic Determinants of the Neuroendocrine Phenotype As Biomarkers for Neuroendocrine Neoplasms

Role: collaborator

NCT06699992Not Yet Recruiting

Clinical Application and Usability of Blood Biomarkers As Screening Tool in Alzheimer Disease: a Validation Study

Role: collaborator

NCT05614856Suspended

Aorto-iliac Occlusion Treatment With ShorT Unibody aorTic Endograft - ASTUTE Study

Role: collaborator

NCT05946421Unknown

The BASA Study: Breath Analysis for Severe Asthma Patients

Role: lead

NCT05781802Unknown

V/Q Matching in Pressure Support Ventilation

Role: lead

NCT04986332Not ApplicableRecruiting

Multidimensional Approach for COPD and High Complexity

Role: lead

NCT03496233Phase 3Completed

Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in G1b Treatment-Naïve, HCV-Infected Patients

Role: lead

NCT04853836Phase 4Completed

Olfactory Disfunction and Co-ultraPEALut

Role: collaborator

NCT04102813Not ApplicableCompleted

Deep Diaphragmatic Breathing: Neurobiological and Anti-inflammatory Effects

Role: lead

NCT04655638Not ApplicableCompleted

HFNT vs. COT in COVID-19

Role: lead

NCT05057598Not ApplicableRecruiting

DianaWeb: Before and After Study Online Based Participatory Research on Breast Cancer Women

Role: collaborator

NCT04643054Not ApplicableUnknown

Efficacy and Safety of Ovotransferrin in COVID-19 Patients

Role: lead

NCT04623619Not ApplicableUnknown

Efficacy and Safety of Acetyl L-Carnitine in COVID-19 Patients With Mild-to-Moderate Disease

Role: lead

NCT03946267Not ApplicableCompleted

Infracyanine Green vs Brilliant Blue G in Macular Hole Inverted Flap Surgery: A Swept Source OCT Analysis.

Role: lead